Article Details
Retrieved on: 2020-12-22 00:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A study of nearly 9,300 people who had taken the anti-interleukin-12/23p40 monoclonal antibody ustekinumab found people with high baseline ...
Article found on: www.dermatologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here